全球生物技術市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球生技市場預計將從2025年的1,4,481億美元成長至2034年的4,8,637.9億美元，並預計在2026年至2034年間以14.41%的複合年成長率成長。隨著生物技術的應用不斷變革醫療保健、農業和工業流程，全球生技市場正經歷快速擴張。生物技術是利用生物系統和生物體開發疫苗、生物製藥、基因改造作物和診斷工具等產品的技術。生命科學研發投入的不斷增加以及對創新醫療手段日益成長的需求是推動市場成長的主要因素。

基因編輯、合成生物學和生物資訊學等技術的進步正顯著加速新型生物技術解決方案的開發。製藥公司和研究機構正擴大利用生物技術開發標靶治療和個人化醫療。政府資助以及學術機構與生技公司之間的合作也正在推動這項產業的發展。

隨著對先進療法和永續生物產品的需求不斷成長，生物技術市場預計將進一步擴大。在醫療保健、農業和環境管理等領域的應用不斷拓展，將持續創造新的機會。持續的研究和創新將在塑造生物技術產業的未來中發揮至關重要的作用。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：本節詳細評估影響市場成長的主要促進因素、限制因素、機會和挑戰。內容涵蓋技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球生技市場：依技術分類

• 市場分析、洞察與預測
• 奈米生物技術
• 組織工程與再生醫學
• DNA定序
• 基於細胞的檢測
• 發酵
• PCR技術
• 層析法
• 其他

第5章 全球生技市場：依應用分類

• 市場分析、洞察與預測
• 衛生保健
• 食品和農業
• 自然資源/環境
• 工業流程
• 生物資訊學
• 其他

第6章 全球生技市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • AstraZeneca
  • Gilead Sciences Inc
  • Bristol-Myers Squibb
  • Sanofi
  • Biogen
  • Abbott Laboratories
  • Pfizer Inc
  • Amgen Inc
  • Novo Nordisk A/S
  • Merck KGaA
  • Johnson & Johnson Services Inc

The global biotechnology market size is expected to reach USD 4863.79 Billion in 2034 from USD 1448.10 Billion in 2025, growing at a CAGR of 14.41 during 2026-2034.The global biotechnology market is experiencing rapid expansion as biotechnology applications continue to transform healthcare, agriculture, and industrial processes. Biotechnology involves the use of biological systems and organisms to develop products such as vaccines, biologic drugs, genetically engineered crops, and diagnostic tools. Increasing investments in life sciences research and the growing demand for innovative medical treatments are major factors driving market growth.

Advancements in technologies such as gene editing, synthetic biology, and bioinformatics are significantly accelerating the development of new biotechnology solutions. Pharmaceutical companies and research institutions are increasingly utilizing biotechnology to develop targeted therapies and personalized medicines. Government funding and collaborations between academic institutions and biotech companies are also strengthening the industry.

Looking ahead, the biotechnology market is expected to grow further as demand for advanced therapies and sustainable bioproducts increases. Expanding applications in healthcare, agriculture, and environmental management will continue to create new opportunities. Continuous research and technological innovation will play a key role in shaping the future of the biotechnology industry.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Technology

• Nanobiotechnology
• Tissue Engineering and Regeneration
• DNA Sequencing
• Cell-based Assays
• Fermentation
• PCR Technology
• Chromatography
• Others

By Application

• Health
• Food & Agriculture
• Natural Resources & Environment
• Industrial Processing
• Bioinformatics
• Others

COMPANIES PROFILED

• AstraZeneca, Gilead Sciences Inc., Bristol-Myers Squibb, Sanofi, Biogen, Abbott Laboratories, Pfizer Inc., Amgen Inc., Novo Nordisk A/S, Merck KGaA, Johnson & Johnson Services Inc

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOTECHNOLOGY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Nanobiotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Tissue Engineering and Regeneration Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. DNA Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Cell-based Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Fermentation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. PCR Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOTECHNOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Health Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Food & Agriculture Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Natural Resources & Environment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Industrial Processing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Bioinformatics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOTECHNOLOGY MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Technology
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Technology
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Technology
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Technology
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Technology
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL BIOTECHNOLOGY INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 AstraZeneca
  • 8.2.2 Gilead Sciences Inc
  • 8.2.3 Bristol-Myers Squibb
  • 8.2.4 Sanofi
  • 8.2.5 Biogen
  • 8.2.6 Abbott Laboratories
  • 8.2.7 Pfizer Inc
  • 8.2.8 Amgen Inc
  • 8.2.9 Novo Nordisk A/S
  • 8.2.10 Merck KGaA
  • 8.2.11 Johnson & Johnson Services Inc